did fda ban tirzepatide confirms shortage is still over, gives compounders a grace period Compounded GLP-1 ban: What providers

Novo Nordisk shares jumped 8% Monday after Hims & Herssaid it will pull its copycat weight-loss pill off the market.

The discovery offers an explanation for why [...]

This month pharmacies will no longer be allowed to sell lower-cost compounded versions of the anti-obesity drug tirzepatide and costs to consumers will triple, from $350 a month to $1,000.

Shaklee, a global pioneer in science-backed wellness and nutrition, introduced its latest innovation: Shaklee Sparkling Protein.

Learn how long you should take Mounjaro or Zepbound, what happens when you stop, and factors that determine treatment duration for diabetes and weight management.